What metrics would you use to evaluate Verily's Onduo virtual diabetes management program?

Introduction

Evaluating the success of Verily's Onduo virtual diabetes management program requires a comprehensive approach to product metrics. To address this product success metrics challenge effectively, I'll follow a structured framework that covers core metrics, supporting indicators, and risk factors while considering all key stakeholders.

Step 1

Product Context

Onduo is a virtual diabetes management program developed by Verily, a subsidiary of Alphabet. It combines connected devices, coaching, and personalized insights to help people with diabetes better manage their condition.

Key stakeholders include:

1. Patients with diabetes: Seeking improved health outcomes and quality of life
2. Healthcare providers: Looking for better patient outcomes and efficient care delivery
3. Payers (insurance companies): Aiming to reduce healthcare costs
4. Verily/Alphabet: Pursuing business growth and innovation in healthcare

User flow:

1. Onboarding: Users sign up, provide health information, and receive a welcome kit with connected devices.
2. Daily monitoring: Patients use connected glucose monitors and other devices to track their health data.
3. Personalized insights: The platform analyzes data to provide tailored recommendations.
4. Coaching: Users interact with health coaches for guidance and support.
5. Provider integration: Health data is shared with the patient's healthcare team for coordinated care.

Onduo fits into Verily's broader strategy of leveraging technology to improve healthcare outcomes and reduce costs. It competes with other digital health platforms like Livongo and Omada Health, but differentiates itself through its connection to Verily's advanced data analytics and AI capabilities.

Product Lifecycle Stage: Onduo is in the growth stage, having moved beyond initial launch and now focusing on expanding its user base and refining its offering based on real-world data and feedback.